Neuralink Launches New Trial: Brain Implant and Robotic Arm Aid Paralyzed Patients

Elon Musk’s brain-tech startup Neuralink announced on Monday that it has received approval to launch a new study aimed at evaluating the feasibility of its brain implants and experimental robotic arms. Building on its ongoing PRIME project, the study will focus on assessing the safety of wireless brain-computer interfaces and surgical robots, while conducting preliminary tests on the ability of these implants to help quadriplegic patients control external devices with their thoughts.

Neuralink disclosed these plans in a post on the social media platform X, stating that it would cross-recruit participants from the ongoing PRIME trial to further explore the potential of its brain implant technology.

Although the U.S. Food and Drug Administration and Neuralink have not yet disclosed the specific details of the study, this progress marks a significant step forward for Neuralink in advancing brain-computer interface technology.

Neuralink plans to recruit volunteers from existing participants in its PRIME trial for this feasibility study. Last week, the company received approval in Canada to enroll six paralyzed patients in device trials. In the Canadian trial, neurosurgeons collaborating with Neuralink have obtained regulatory approval and are prepared to recruit participants to evaluate the device’s performance in real-world applications.

In the United States, Neuralink has successfully implanted its device in two patients. One patient is already able to play video games, browse the internet, and use social media through thought alone, while the other is currently using the device to play video games and learn 3D design.

It is evident that Neuralink has achieved initial success, as both patients with implanted devices have demonstrated the ability to control external devices using the implant, sending a positive signal for future research and applications.

Responsible Editor: Guo Mingyu